Literature DB >> 10764013

Temperature profile in the nasal cavity.

T Keck1, R Leiacker, H Riechelmann, G Rettinger.   

Abstract

OBJECTIVES/HYPOTHESIS: Inspired air is heated and moistened as it passes the nasal cavity. The temperature increase should be similar to a heated tube model, depending on the airflow. STUDY
DESIGN: Intranasal temperature values of 50 volunteers were measured after inspiration at different locations: nasal vestibule, nasal valve area, anterior to the head of the middle turbinate, and the nasopharynx. Temperature values were related to nasal airway resistance data.
METHODS: Intranasal temperature measurements were made with a miniaturized thermocouple. Nasal airway resistance was detected by active anterior rhinomanometry.
RESULTS: A logarithmic increase of air temperature from the anterior segment of the nose to the posterior part was noted. In the nasopharynx temperature was approximately 34 degrees C. The highest increase in temperature was observed in the nasal valve area.
CONCLUSIONS: The temperature increase of ambient air in the nasal airways can be compared with a logarithmic curve of the heating of air passing a heated tube. As the heating of air is important for water transport, the space between the nasal valve and the middle turbinate is of special functional importance. No correlation to the results of rhinomanometry was found.

Entities:  

Mesh:

Year:  2000        PMID: 10764013     DOI: 10.1097/00005537-200004000-00021

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  46 in total

1.  Evaluation of a temperature-restricted, mucosal tuberculosis vaccine in guinea pigs.

Authors:  Tuhina Gupta; Monica LaGatta; Shelly Helms; Rebecca L Pavlicek; Simon O Owino; Kaori Sakamoto; Tamas Nagy; Stephen B Harvey; Mark Papania; Stephanie Ledden; Kevin T Schultz; Candace McCombs; Frederick D Quinn; Russell K Karls
Journal:  Tuberculosis (Edinb)       Date:  2018-10-19       Impact factor: 3.131

2.  Numerical simulation of humidification and heating during inspiration in nose models with three different located septal perforations.

Authors:  Jörg Lindemann; Michael Reichert; Ralf Kröger; Patrick Schuler; Thomas Hoffmann; Fabian Sommer
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-11-06       Impact factor: 2.503

Review 3.  The physiological rationale of heat and moisture exchangers in post-laryngectomy pulmonary rehabilitation: a review.

Authors:  J K Zuur; S H Muller; F H C de Jongh; N van Zandwijk; F J M Hilgers
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-07-07       Impact factor: 2.503

4.  Thermoreversible-mucoadhesive gel for nasal delivery of sumatriptan.

Authors:  Rita J Majithiya; Pradip K Ghosh; Manish L Umrethia; Rayasa S R Murthy
Journal:  AAPS PharmSciTech       Date:  2006-08-04       Impact factor: 3.246

5.  Temperature profile of the nasal cavity in Japanese macaques.

Authors:  Takeshi Nishimura; Akihisa Kaneko
Journal:  Primates       Date:  2019-08-19       Impact factor: 2.163

6.  A Role of Epithelial Cells and Virulence Factors in Biofilm Formation by Streptococcus pyogenes In Vitro.

Authors:  Feiruz Alamiri; Yashuan Chao; Maria Baumgarten; Kristian Riesbeck; Anders P Hakansson
Journal:  Infect Immun       Date:  2020-09-18       Impact factor: 3.441

Review 7.  [Nasal turbinate surgery].

Authors:  F Sommer; J Lindemann; M-O Scheithauer; T K Hoffmann; J A Veit
Journal:  HNO       Date:  2017-05       Impact factor: 1.284

8.  The Pneumococcal Type 1 Pilus Genes Are Thermoregulated and Are Repressed by a Member of the Snf2 Protein Family.

Authors:  Alan Basset; Muriel Herd; Raecliffe Daly; Simon L Dove; Richard Malley
Journal:  J Bacteriol       Date:  2017-07-11       Impact factor: 3.490

9.  Targeted Lung Delivery of Nasally Administered Aerosols.

Authors:  Geng Tian; Michael Hindle; P Worth Longest
Journal:  Aerosol Sci Technol       Date:  2014       Impact factor: 2.908

10.  Delivery to the lower respiratory tract is required for effective immunization with Newcastle disease virus-vectored vaccines intended for humans.

Authors:  Joshua M DiNapoli; Jerrold M Ward; Lily Cheng; Lijuan Yang; Subbiah Elankumaran; Brian R Murphy; Siba K Samal; Peter L Collins; Alexander Bukreyev
Journal:  Vaccine       Date:  2009-01-23       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.